Covestor’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Covestor's AMPH Position: Q3 2026 in Review
Covestor increased its Amphastar Pharmaceuticals (AMPH) stake by 35% in Q3 2026, buying an estimated $497 and bringing the position to 88 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1949.
Covestor first reported a position in AMPH in Q4 2021 and has held it in 20 quarters since. The position peaked at $90K in Q3 2023. 175 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.
- Covestor held 88 shares of Amphastar Pharmaceuticals worth $2K as of Q3 2026.
- Covestor bought 23 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $497.
- Amphastar Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #1949 holding.
- Covestor first reported a position in Amphastar Pharmaceuticals in Q4 2021 and has held it in 20 quarters since.
- Covestor's Amphastar Pharmaceuticals position peaked at $90K in Q3 2023.
- 175 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.